Autopsy report · NCT02269111
Quantitative MRI in Assessing Disease in Patients With Brain Tumors
Cause of deathFunding or business, also staffing, sites or logistics
“Change in PI and funding”
Life of this trial
- Registered 6 months before it started.
- Ran for about 3 years 1 month before it stopped.
- 10 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Tumors Metastatic to Brain; Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- diffusion-weighted magnetic resonance imaging; chemical exchange saturation transfer magnetic resonance imaging; dynamic contrast-enhanced magnetic resonance imaging; dynamic susceptibility contrast-enhanced magnetic resonance imaging
- Participants
- 10
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Pudendal vs Caudal Block for Pediatric Penile Surgery
“Lack of funding and change of PI” - Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
“Funding and PI leaving institution” - Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks
“Funding changes.” - Role of the Auditory Efferent System in Auditory Perceptual Learning
“PI change of institution” - Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
“PI changed institutions”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.